Literature DB >> 8769085

Downregulation of endothelial constitutive nitric oxide synthase expression by lipopolysaccharide.

J L Lu1, L M Schmiege, L Kuo, J C Liao.   

Abstract

Lipopolysaccharide (LPS), a causal agent of sepsis, has been shown to induce systemic nitric oxide (NO) synthesis through complex mechanisms. However, the effect of LPS on endothelial cells is incompletely understood. To investigate the mechanism by which LPS influences the release of NO from endothelial cells, the effect of this compound on endothelial constitutive nitric oxide synthase (ecNOS) was studied in cultured bovine coronary venular endothelial cells. Western and Northern analyses showed that LPS decreased ecNOS expression at the protein and mRNA levels in a time-dependent and dose-responsive manner. Concurrent treatment of the endothelial cells with LPS and a transcription inhibitor, actinomycin D, resulted in decreased ecNOS mRNA within 8 hours. In contrast, treatment with actinomycin D had only a relatively insignificant effect on the ecNOS transcript level. This result suggests that the reduction of ecNOS by LPS resulted from an increased degradation rate of its transcript.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8769085     DOI: 10.1006/bbrc.1996.1121

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  15 in total

1.  Inhaled NO as a viable antiadhesive therapy for ischemia/reperfusion injury of distal microvascular beds.

Authors:  A Fox-Robichaud; D Payne; S U Hasan; L Ostrovsky; T Fairhead; P Reinhardt; P Kubes
Journal:  J Clin Invest       Date:  1998-06-01       Impact factor: 14.808

2.  Weaning induces NOS-2 expression through NF-kappaB modulation in the lactating mammary gland: importance of GSH.

Authors:  Rosa Zaragozá; Vicente J Miralles; A Diana Rus; Concha García; Rafael Carmena; Elena R García-Trevijano; Teresa Barber; Federico V Pallardó; Luís Torres; Juan R Viña
Journal:  Biochem J       Date:  2005-11-01       Impact factor: 3.857

3.  Piroxicam reverses endotoxin-induced hypotension in rats: contribution of vasoactive eicosanoids and nitric oxide.

Authors:  C Kemal Buharalioglu; Belma Korkmaz; Tuba Cuez; Seyhan Sahan-Firat; Ayse Nihal Sari; Kafait U Malik; Bahar Tunctan
Journal:  Basic Clin Pharmacol Toxicol       Date:  2011-05-06       Impact factor: 4.080

4.  Sphingosine-1-phosphate attenuates lung injury induced by intestinal ischemia/reperfusion in mice: role of inducible nitric-oxide synthase.

Authors:  Renyu Ding; Jiali Han; Yu Tian; Renxuan Guo; Xiaochun Ma
Journal:  Inflammation       Date:  2012-02       Impact factor: 4.092

5.  A synthetic analogue of 20-HETE, 5,14-HEDGE, reverses endotoxin-induced hypotension via increased 20-HETE levels associated with decreased iNOS protein expression and vasodilator prostanoid production in rats.

Authors:  Tuba Cuez; Belma Korkmaz; C Kemal Buharalioglu; Seyhan Sahan-Firat; John Falck; Kafait U Malik; Bahar Tunctan
Journal:  Basic Clin Pharmacol Toxicol       Date:  2009-12-07       Impact factor: 4.080

6.  Mechanisms of nitric oxide synthase uncoupling in endotoxin-induced acute lung injury: role of asymmetric dimethylarginine.

Authors:  Shruti Sharma; Anita Smith; Sanjiv Kumar; Saurabh Aggarwal; Imran Rehmani; Connie Snead; Cynthia Harmon; Jeffery Fineman; David Fulton; John D Catravas; Stephen M Black
Journal:  Vascul Pharmacol       Date:  2009-12-03       Impact factor: 5.773

7.  Active stabilization of human endothelial nitric oxide synthase mRNA by hnRNP E1 protects against antisense RNA and microRNAs.

Authors:  J J David Ho; G Brett Robb; Sharon C Tai; Paul J Turgeon; Imtiaz A Mawji; H S Jeffrey Man; Philip A Marsden
Journal:  Mol Cell Biol       Date:  2013-03-11       Impact factor: 4.272

8.  Low endotoxemia prevents the reduction of gastric blood flow induced by NSAIDs: role of nitric oxide.

Authors:  Sara Calatayud; Amparo Canet; Regina Bello; Carlos Hernández; Miguel Martí; M Dolores Barrachina
Journal:  Br J Pharmacol       Date:  2003-05       Impact factor: 8.739

9.  Heat shock protein 90 inhibitors prolong survival, attenuate inflammation, and reduce lung injury in murine sepsis.

Authors:  Anuran Chatterjee; Christiana Dimitropoulou; Fotios Drakopanayiotakis; Galina Antonova; Connie Snead; Joseph Cannon; Richard C Venema; John D Catravas
Journal:  Am J Respir Crit Care Med       Date:  2007-07-05       Impact factor: 21.405

Review 10.  Endothelial NOS: perspective and recent developments.

Authors:  Victor Garcia; William C Sessa
Journal:  Br J Pharmacol       Date:  2018-12-09       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.